Suppr超能文献

益生菌预防和治疗儿童抗生素相关性腹泻的系统评价概述

Overview of systematic reviews of probiotics in the prevention and treatment of antibiotic-associated diarrhea in children.

作者信息

Yang Qingrui, Hu Zeyu, Lei Yuyu, Li Xinzhu, Xu Chao, Zhang Jie, Liu Haitao, Du Xiaoquan

机构信息

The First Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, China.

Department of Gastroenterology, The Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China.

出版信息

Front Pharmacol. 2023 Jul 24;14:1153070. doi: 10.3389/fphar.2023.1153070. eCollection 2023.

Abstract

Antibiotics alter the microbial balance commonly resulting in antibiotic-associated diarrhea (AAD). Probiotics may prevent and treat AAD by providing the gut barrier and restoring the gut microflora. This study will overview the Systematic Reviews (SRs) of probiotics in preventing and treating AAD in children. It will also assess the reporting, methodological, and evidence quality of the included SRs to provide evidence for their clinical practice. After searching PubMed, Embase, Cochrane Library, CNKI, CBM, VIP, and WanFang Data databases, and finally included SRs of probiotics in the prevention and treatment of AAD in children, which were published before 1 October 2022. The reporting, methodological, and evidence quality of the included SRs were assessed by PRISMA 2020 statement, AMSTAR 2 tool, and GRADE system. A total of 20 SRs were included, and the results of PRISMA 2020 showed that 4 out of 20 SRs with relatively complete reporting, and the others within some reporting deficiencies, with scores ranging from 17 points to 26.5 points; the results of AMSTAR 2 showed that 3 SRs belonged to moderate quality level, 10 SRs belonged to low-quality level and 7 SRs being extremely low-quality level; the results of the GRADE system showed that a total of 47 outcomes were reported for the included SRs, three were high-level evidence quality, 16 were medium-level evidence quality, 24 were low-level evidence quality, and four were extremely low-level evidence quality; the results of the Meta-analysis showed that high doses (5-40 billion CFUs per day) of probiotics had a significant effect in the prevention of AAD, but it is too early to conclude the effectiveness and safety of other probiotic drugs for AAD in children, except for and Current evidence shows that probiotics effectively prevent and treat AAD in children, and the effect of probiotics on pediatric AAD may be a potential dose-response effect. However, the conclusion should be treated with caution due to deficiencies in the methodological, reporting, and evidence quality of the included SRs. Therefore, the methodological, reporting, and evidence quality of relevant SRs still need further improvement. https://www.crd.york.ac.uk/prospero/, identifier CRD42022362328.

摘要

抗生素会改变微生物平衡,通常会导致抗生素相关性腹泻(AAD)。益生菌可以通过提供肠道屏障和恢复肠道微生物群来预防和治疗AAD。本研究将概述益生菌预防和治疗儿童AAD的系统评价(SRs)。它还将评估纳入的SRs的报告、方法和证据质量,以为临床实践提供证据。在检索了PubMed、Embase、Cochrane图书馆、中国知网、中国生物医学文献数据库、维普资讯和万方数据数据库后,最终纳入了2022年10月1日前发表的关于益生菌预防和治疗儿童AAD的SRs。采用PRISMA 2020声明、AMSTAR 2工具和GRADE系统对纳入的SRs的报告、方法和证据质量进行评估。共纳入20篇SRs,PRISMA 2020结果显示,20篇SRs中有4篇报告相对完整,其他报告存在一些缺陷,得分在17分至26.5分之间;AMSTAR 2结果显示,3篇SRs属于中等质量水平,10篇SRs属于低质量水平,7篇SRs属于极低质量水平;GRADE系统结果显示,纳入的SRs共报告了47项结果,3项为高级别证据质量,16项为中级别证据质量,24项为低级别证据质量,4项为极低级别的证据质量;Meta分析结果显示,高剂量(每天50亿至400亿CFU)益生菌对预防AAD有显著效果,但除了[具体益生菌名称1]和[具体益生菌名称2]外,目前得出其他益生菌药物对儿童AAD有效性和安全性的结论还为时过早。目前的证据表明,益生菌能有效预防和治疗儿童AAD,益生菌对儿童AAD的作用可能存在潜在的剂量反应效应。然而,由于纳入的SRs在方法、报告和证据质量方面存在缺陷,该结论应谨慎对待。因此,相关SRs的方法、报告和证据质量仍需进一步提高。https://www.crd.york.ac.uk/prospero/,标识符CRD42022362328

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/363f/10411537/1e42f71c2383/fphar-14-1153070-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验